Creyos Shines in Alzheimer's Research at the 2025 AAIC Conference

Creyos, a pioneering digital platform, has made notable strides in the realm of brain health research, particularly highlighted during the Alzheimer’s Association International Conference (AAIC) held in 2025. Recognized for its precision in cognitive assessments, Creyos was prominently featured in three separate research presentations, reflecting its trusted status among clinicians and researchers. These studies are a testimony to Creyos' significant impact on cognitive health, particularly in the early detection of Alzheimer's disease.

Innovative Research and Early Detection

The studies presented at the AAIC demonstrate the value of Creyos in understanding cognitive ailments associated with aging. Developed from over three decades of neuroscience research, Creyos has been validated across more than 400 peer-reviewed studies, enabling researchers to accurately measure critical cognitive domains like memory, attention, reasoning, and executive function.

Adrian Owen, a Professor of Cognitive Neuroscience at Western University and Chief Scientific Officer at Creyos, emphasized that the platform was not merely a product of corporate ambition but rather a direct response to challenges researchers face in measuring cognition comprehensively. It was crafted to address a gap in reliable data collection for cognitive health studies, enabling hundreds of researchers worldwide to build upon its foundational principles.

Key Findings from AAIC Presentations

1. Digital Task for Early Screening
Researchers at Western University conducted an innovative study using data from over 4,000 older adults. By utilizing machine learning, they identified two key Creyos tasks that effectively predict cognitive impairment related to aging. Their findings indicated that a screener based on these tasks matched the rates of mild cognitive impairment documented in a larger validation sample, marking Creyos as a formidable alternative to traditional screening methods for dementia.

2. Genetic Risk Assessment & Online Testing
In a groundbreaking study by QIMR Berghofer, the validity of the Creyos platform was tested against traditional in-person testing methods. This study focused on individuals aged 42 to 75 participating in the Prospective Imaging Study of Aging. The strong correlation between Creyos assessments and conventional testing reinforced the potential of online cognitive testing as an efficient and economical approach to early detection in Alzheimer's research.

3. Exploring Cognitive Resilience
A fascinating exploration by the Rotman Research Institute aimed at understanding why some individuals retain cognitive functionality despite age-associated deterioration or trauma. This study evaluated over 3,300 participants, identifying reasoning abilities as a potential marker of cognitive resilience, a finding that could highlight new avenues for preserving cognitive health.

These revelations accentuate Creyos' commitment to rigorous scientific standards. The platform's integration into extensive research underscores its growing acceptance within the scientific community, illustrating its role in fostering early detection, speculative care planning, and strategic treatment pathways in healthcare settings.

The Future of Brain Health Assessment

More than just a research tool, Creyos has established itself as a vital resource among healthcare providers across various specialties, including primary care and behavioral health. With nearly 20 million assessments completed and over 10,000 active healthcare providers utilizing the platform, Creyos is redefining standards in measuring brain health, effectively linking the insights garnered from research with practical applications in patient care.

About Creyos

Previously known as Cambridge Brain Sciences, Creyos specializes in developing healthcare technology aimed at revolutionizing how brain health is assessed and managed. Through its comprehensive platform, which includes online tasks and condition-specific assessments, Creyos empowers clinicians by furnishing actionable insights that enhance early intervention efforts and facilitate informed, evidence-based decisions.

For more information about Creyos and its innovative approach to cognitive health, visit www.creyos.com.